Imidazole → 4-[(Tert-butyldimethylsilyl)oxy]-2-chlorobenzaldehyde

HRID 499857Notes

Reaction equation

HRID 499857 reaction equation
[Cl:1][C:2]1[CH:9]=[C:8]([OH:10])[CH:7]=[CH:6][C:3]=1[CH:4]=[O:5].[Si:11](Cl)([C:14]([CH3:17])([CH3:16])[CH3:15])([CH3:13])[CH3:12].N1C=CN=C1>CN(C)C=O>[Si:11]([O:10][C:8]1[CH:7]=[CH:6][C:3]([CH:4]=[O:5])=[C:2]([Cl:1])[CH:9]=1)([C:14]([CH3:17])([CH3:16])[CH3:15])([CH3:13])[CH3:12]

Participants

5

Procedure

A solution of 2-chloro-4-hydroxybenzaldehyde (5.0 g, 32 mmol), tert-butyl(dimethyl)silyl chloride (5.3 g, 35 mmol), imidazole (2.9 g, 45 mmol) and N,N-dimethylaminopyridine (10 mg) in N,N-dimethylformamide (40 ml) was stirred at room temperature under a nitrogen atmosphere for 16 hours. The solvent was removed in vacuo and the residue partitioned between ethyl acteate (100 ml) and water (100 ml). The organic phase was separated, washed with sat. aq. sodium chloride (50 ml), dried (sodium sulfate) and reduced in vacuo. Further purification by column chromatography on silica gel eluting with pentane:ethyl acetate (3:1 changing to 2:1) gave the title compound as a colourless oil (6.50 g).

Workup

  1. customThe solvent was removed in vacuo
  2. customthe residue partitioned between ethyl acteate (100 ml) and water (100 ml)
  3. customThe organic phase was separated
  4. washwashed with sat. aq. sodium chloride (50 ml)
  5. dry with materialdried (sodium sulfate)
  6. customFurther purification by column chromatography on silica gel eluting with pentane:ethyl acetate (3:1 changing to 2:1)

Sources & evidence

ORD record
ord-367cdecaeb4c423f903dc759cd0de251
Source dataset
uspto-grants-2010_08
Patent number
US07767715B2

Reaction notes

Loading…